Sera Prognostics (SERA) Expected to Announce Earnings on Wednesday

Sera Prognostics (NASDAQ:SERA - Get Free Report) is projected to issue its Q1 2025 quarterly earnings data before the market opens on Wednesday, May 14th. Analysts expect the company to announce earnings of ($0.24) per share and revenue of $0.06 million for the quarter.

Sera Prognostics (NASDAQ:SERA - Get Free Report) last issued its quarterly earnings results on Wednesday, March 19th. The company reported ($0.25) earnings per share for the quarter, missing the consensus estimate of ($0.23) by ($0.02). The company had revenue of $0.02 million during the quarter, compared to the consensus estimate of $0.01 million. During the same quarter last year, the firm posted ($0.25) earnings per share. On average, analysts expect Sera Prognostics to post $-1 EPS for the current fiscal year and $-1 EPS for the next fiscal year.

Sera Prognostics Trading Down 10.0 %

Shares of Sera Prognostics stock opened at $2.52 on Wednesday. The business has a fifty day simple moving average of $3.59 and a two-hundred day simple moving average of $5.61. The firm has a market capitalization of $94.91 million, a P/E ratio of -2.55 and a beta of 0.99. Sera Prognostics has a 12 month low of $2.51 and a 12 month high of $10.23.

About Sera Prognostics

Sera Prognostics, Inc, a women's health diagnostic company, discovers, develops, and commercializes biomarker tests for improving pregnancy outcomes in the United States. The company develops PreTRM test, a blood-based biomarker test to predict the risk of spontaneous preterm birth in singleton pregnancies.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.